KOHBERG TANDKLINIK I/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Bankruptcy risk for industry  0.5% 0.5% 0.5% 0.5% 0.5%  
Bankruptcy risk  1.7% 2.5% 2.5% 2.8% 2.3%  
Credit score (0-100)  74 62 61 59 63  
Credit rating  A BBB BBB BBB BBB  
Credit limit (kDKK)  6.6 0.0 0.0 0.0 0.1  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5

Net sales  0 0 0 0 0  
Gross profit  8,928 11,626 10,848 8,586 9,830  
EBITDA  5,173 6,655 6,541 4,966 5,074  
EBIT  4,917 6,424 6,312 4,643 4,792  
Pre-tax profit (PTP)  4,925.3 6,430.5 6,316.7 4,661.6 4,821.5  
Net earnings  4,925.3 6,430.5 6,316.7 4,661.6 4,821.5  
Pre-tax profit without non-rec. items  4,925 6,431 6,317 4,662 4,821  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5

Tangible assets total  817 663 1,027 815 644  
Shareholders equity total  1,855 2,625 2,195 1,585 1,502  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  3,332 3,986 3,460 2,446 2,774  

Net Debt  -1,675 -2,298 -1,546 -648 -272  
 
See the entire balance sheet

Volume 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  8,928 11,626 10,848 8,586 9,830  
Gross profit growth  -20.7% 30.2% -6.7% -20.8% 14.5%  
Employees  10 10 10 10 10  
Employee growth %  -23.1% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  3,332 3,986 3,460 2,446 2,774  
Balance sheet change%  -8.4% 19.6% -13.2% -29.3% 13.4%  
Added value  5,173.4 6,654.9 6,540.9 4,871.5 5,074.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -343 -384 135 -534 -454  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  55.1% 55.3% 58.2% 54.1% 48.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  141.5% 175.9% 170.0% 158.1% 184.7%  
ROI %  222.2% 287.4% 262.6% 247.0% 312.3%  
ROE %  221.9% 287.1% 262.1% 246.6% 312.3%  

Solidity 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Equity ratio %  55.7% 65.9% 63.4% 64.8% 54.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -32.4% -34.5% -23.6% -13.0% -5.4%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Quick Ratio  1.5 2.3 1.7 1.6 1.2  
Current Ratio  1.7 2.4 1.9 1.9 1.7  
Cash and cash equivalent  1,675.3 2,297.8 1,545.7 647.7 271.9  

Capital use efficiency 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  1,038.5 1,961.8 1,168.5 770.3 858.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Net sales / employee  0 0 0 0 0  
Added value / employee  517 665 654 487 507  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  517 665 654 497 507  
EBIT / employee  492 642 631 464 479  
Net earnings / employee  493 643 632 466 482